| 标题 |
214MO Sacituzumab govitecan (SG) efficacy in hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) metastatic breast cancer (MBC) by HER2 immunohistochemistry (IHC) status in the phase III TROPiCS-02 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:P. Schmid; J. Cortes; F. Marmé; H. Rugo; S. Tolaney; et al 出版日期:2022-09-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)